Co-Diagnostics (LTS:0A50) Cyclically Adjusted Book per Share: $ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0A50 Co-Diagnostics Inc LTS:0A50
54 GF Score
Price $0.98
GF Value $1.75
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Co-Diagnostics Cyclically Adjusted Book per Share?

Co-Diagnostics LTS:0A50 +2.62% 54 Cyclically Adjusted Book per Share is $ as of Jun. 2026. GuruFocus rates LTS:0A50 with a GF Score™ of 54/100 and a GF Value™ of $1.75 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Co-Diagnostics's adjusted book value per share for the three months ended in Jun. 2026 was $2.606. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $ for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-20), Co-Diagnostics's current stock price is $0.9849. Co-Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $. Co-Diagnostics's Cyclically Adjusted PB Ratio of today is .

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Co-Diagnostics was 0.25. The lowest was 0.02. And the median was 0.05.


Co-Diagnostics  (LTS:0A50) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Co-Diagnostics was 0.25. The lowest was 0.02. And the median was 0.05.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Co-Diagnostics Cyclically Adjusted Book per Share Related Terms


Co-Diagnostics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Co-Diagnostics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Co-Diagnostics Cyclically Adjusted Book per Share Chart

Co-Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Co-Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

LTS:0A50 vs AIDX, TRIB, ICCM: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Co-Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Co-Diagnostics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Co-Diagnostics's Cyclically Adjusted PB Ratio falls into.


LTS:0A50
54GF Score
Co-Diagnostics Inc LTS:0A50
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Co-Diagnostics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Co-Diagnostics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.606/333.9520*333.9520
=2.606

Current CPI (Jun. 2026) = 333.9520.

Co-Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
201609 241.428 0.000
201612 -66.286 241.432 -91.688
201703 -81.770 243.801 -112.006
201706 -13.343 244.955 -18.191
201709 12.674 246.819 17.148
201712 9.378 246.524 12.704
201803 6.243 249.554 8.354
201806 3.020 251.989 4.002
201809 0.302 252.439 0.400
201812 -2.458 251.233 -3.267
201903 9.809 254.202 12.886
201906 8.423 256.143 10.982
201909 5.769 256.759 7.503
201912 3.005 256.974 3.905
202003 20.947 258.115 27.101
202006 38.291 257.797 49.602
202009 56.222 260.280 72.136
202012 70.064 260.474 89.829
202103 79.807 264.877 100.619
202106 90.619 271.696 111.383
202109 103.989 274.310 126.599
202112 119.286 278.802 142.882
202203 130.398 287.504 151.465
202206 128.301 296.311 144.599
202209 130.939 296.808 147.325
202212 111.283 296.797 125.214
202303 108.346 301.836 119.874
202306 100.782 305.109 110.309
202309 97.352 307.789 105.627
202312 82.548 306.746 89.869
202403 75.150 312.332 80.352
202406 68.062 314.175 72.346
202409 59.929 315.301 63.474
202412 48.898 315.605 51.741
202503 42.821 319.799 44.716
202506 34.109 322.561 35.314
202509 24.819 324.800 25.518
202512 9.846 324.054 10.147
202603 4.453 330.213 4.503
202606 2.606 333.952 2.606

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $ mean?
Co-Diagnostics (LTS:0A50) has a Cyclically Adjusted Book per Share of $ as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Co-Diagnostics and its competitors.
Is Co-Diagnostics' Cyclically Adjusted Book per Share too high?
Co-Diagnostics' current Cyclically Adjusted Book per Share is $. Overall, Co-Diagnostics has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Co-Diagnostics' Cyclically Adjusted Book per Share compare to AIDX and TRIB?
Co-Diagnostics' Cyclically Adjusted Book per Share of $ can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Co-Diagnostics and its competitors. Co-Diagnostics's current Cyclically Adjusted Book per Share is $. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Co-Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Co-Diagnostics (LTS:0A50) is currently considered Possible Value Trap. The stock's GF Value™ is $1.75, compared to a current price of $0.98 — trading 43.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is $. Co-Diagnostics' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Co-Diagnostics (LTS:0A50), the current Cyclically Adjusted Book per Share is $ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Co-Diagnostics (LTS:0A50) Overvalued in 2026?

Based on GuruFocus' analysis, Co-Diagnostics stock appears to be undervalued. The current stock price of $0.98 is trading 43.7% below its estimated GF Value™ of $1.75. GuruFocus considers Co-Diagnostics to be Possible Value Trap.

Key valuation signals for LTS:0A50:

  • Cyclically Adjusted Book per Share: $
  • GF Value™: $1.75 vs. price of $0.98 (43.7% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the LTS:0A50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Co-Diagnostics Business Description

Other Exchanges CODX:USA
Address 2401 S. Foothill Drive, Suite D, Salt Lake City, UT, USA, 84109
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
54GF Score

Get the complete analysis for LTS:0A50

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.98
Price
$1.75
GF Value